Trial intelligence / Profile preview

Remimazolam vs propofol for sedation during gastroscopy in elderly patients

ChiCTR2000039076Phase 4Recruiting

Sponsor
Guiqian International General Hospital
Start
Nov 2020
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in None comparing Remimazolam group, Remimazolam + flumazenil group and Propofol group (3 arms). Primary endpoints: Corticotropin (ACTH), Intraoperative vital signs and 7 more. Started Nov 2020; status: recruiting.

02

Drugs

remimazolampropofolflumazenil

Beyond the preview

Go deeper on ChiCTR2000039076.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000039076.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call